CAR T Cells Drive Outcomes in MMMedPage TodayCHICAGO — Engineered immune cells showed promise in relapsed and refractory multiple myeloma, with two studies demonstrating impressive, but early, results. Researchers from China reported that T cells modi… Continue reading
Laboratory Equipment |
Immunotherapy Shows Unprecedented Promise
Laboratory Equipment “Although it has conceptually been in development over a century, cancer immunotherapy in the last couple of years has really revolutionized treatment options for several patients who had previously untreatable cancers, and it has also been a paradigm … Greater gut bacteria diversity linked to longer progression-free survival in metastatic melanoma patientsNews-Medical.net |
Laboratory Equipment |
Immunotherapy Shows Unprecedented Promise
Laboratory Equipment “Although it has conceptually been in development over a century, cancer immunotherapy in the last couple of years has really revolutionized treatment options for several patients who had previously untreatable cancers, and it has also been a paradigm … Greater gut bacteria diversity linked to longer progression-free survival in metastatic melanoma patientsNews-Medical.net |
News-Medical.net |
New immunotherapy sends multiple myeloma into remission
News-Medical.net “This serves as proof that immunotherapy and precision medicine research pays off. We hope that future research builds on this success in multiple myeloma and other cancers.” The therapy involves chimeric antigen receptor (CAR) T cells targeting B-cell … Gene-Based Therapy May Thwart a Tough Blood CancerLincoln Journal Star CAR T- Cell Therapy Could Be A Promising Treatment For Multiple Myeloma CancerScience World Report Gene-Based Therapy That Reprograms Immune Cells Offers Hope For Multiple Myeloma CureTech Times ecns all 14 news articles » |